Richardson, Des R.

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy

Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism

Cited by 5,894

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy

Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism

Cited by 2,897

The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer

Kalinowski, D. S., & Richardson, D. R. (2005) · Pharmacological Reviews

Iron Metabolism and DisordersMetal complexes synthesis and properties

Cited by 721

Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol

Richardson, D. R., Lane, D. J. R., Becker, E. M., Huang, M. L.-H., Whitnall, M., Rahmanto, Y. S., Sheftel, A. D., & Ponka, P. (2010) · Proceedings of the National Academy of Sciences

Iron Metabolism and DisordersMitochondrial Function and Pathology

Cited by 536

Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease

Lane, D. J. R., Merlot, A. M., Huang, M. L.-H., Bae, D.-H., Jansson, P. J., Sahni, S., Kalinowski, D. S., & Richardson, D. R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 399

The iron metabolism of neoplastic cells: Alterations that facilitate proliferation?

Kwok, J. C., & Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 215

Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant

Huang, M. L.-H., Becker, E. M., Whitnall, M., Rahmanto, Y. S., Ponka, P., & Richardson, D. R. (2009) · Proceedings of the National Academy of Sciences

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 212

Chelators at the cancer coalface: Desferrioxamine to Triapine and beyond

Yu, Y., Wong, J., Lovejoy, D. B., Kalinowski, D. S., & Richardson, D. R. (2006) · Clinical Cancer Research

Iron Metabolism and DisordersTrace Elements in Health

Cited by 195

The uptake of iron and transferrin by the human malignant melanoma cell

Richardson, D. R., & Baker, E. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Iron Metabolism and DisordersPlant Micronutrient Interactions and Effects

Cited by 179

Iron export through the transporter ferroportin 1 is modulated by the iron chaperone PCBP2

Yanatori, I., Richardson, D. R., Imada, K., & Kishi, F. (2016) · Journal of Biological Chemistry

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 170

CD63 is regulated by iron via the IRE-IRP system and is important for ferritin secretion by extracellular vesicles

Yanatori, I., Richardson, D. R., Dhekne, H. S., Toyokuni, S., & Kishi, F. (2021) · Blood

Extracellular vesicles in diseaseIron Metabolism and Disorders

Cited by 148

Future of ToxicologyIron Chelators and Differing Modes of Action and Toxicity: The Changing Face of Iron Chelation Therapy

Kalinowski, D. S., & Richardson, D. R. (2007) · Chemical Research in Toxicology

Iron Metabolism and DisordersMetal complexes synthesis and properties

Cited by 145

Pyridoxal isonicotinoyl hydrazone and its analogs: Potential orally effective iron-chelating agents for the treatment of iron overload disease

Richardson, D. R., & Ponka, P. (1998) · Journal of Laboratory and Clinical Medicine

Iron Metabolism and DisordersHemoglobinopathies and Related Disorders

Cited by 126

Iron: A New Target for Pharmacological Intervention in Neurodegenerative Diseases

Whitnall, M., & Richardson, D. R. (2006) · Seminars in Pediatric Neurology

Neurological diseases and metabolismIron Metabolism and Disorders

Cited by 113

Mitochondrial Mayhem: The Mitochondrion as a Modulator of Iron Metabolism and Its Role in Disease

Huang, M. L.-H., Lane, D. J. R., & Richardson, D. R. (2011) · Antioxidants & Redox Signaling

Iron Metabolism and DisordersMitochondrial Function and Pathology

Cited by 103

Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators

Lovejoy, D., & Richardson, D. (2003) · Current Medicinal Chemistry

Iron Metabolism and DisordersMetal complexes synthesis and properties

Cited by 98

Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury

Bendova, P., Mackova, E., Haskova, P., Vavrova, A., Jirkovsky, E., Sterba, M., Popelova, O., Kalinowski, D. S., Kovarikova, P., Vavrova, K., et al. (2010) · Chemical Research in Toxicology

Iron Metabolism and DisordersAntioxidant Activity and Oxidative Stress

Cited by 73

Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia

Becker, E., & Richardson, D. R. (2001) · The International Journal of Biochemistry & Cell Biology

Genetic Neurodegenerative DiseasesNeurological diseases and metabolism

Cited by 71

The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer

Yanatori, I., Richardson, D. R., Toyokuni, S., & Kishi, F. (2017) · Journal of Biological Chemistry

Heme Oxygenase-1 and Carbon MonoxideHemoglobin structure and function

Cited by 69

24p3 and Its Receptor: Dawn of a New Iron Age?

Richardson, D. R. (2005) · Cell

Iron Metabolism and DisordersCell death mechanisms and regulation

Cited by 64

Therapeutic Potential of Iron Chelators in Cancer Therapy

Richardson, D. R. (2002) · Advances in Experimental Medicine and Biology

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 40

A Nitric Oxide Storage and Transport System That Protects Activated Macrophages from Endogenous Nitric Oxide Cytotoxicity

Lok, H. C., Sahni, S., Jansson, P. J., Kovacevic, Z., Hawkins, C. L., & Richardson, D. R. (2016) · Journal of Biological Chemistry

Nitric Oxide and Endothelin EffectsHemoglobin structure and function

Cited by 36

Orally effective iron chelators for the treatment of iron overload disease: The case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs

Richardson, D. R., & Ponka, P. (1998) · Journal of Laboratory and Clinical Medicine

Iron Metabolism and DisordersHemoglobinopathies and Related Disorders

Cited by 25

Intermediate steps in cellular iron uptake from transferrin. II. A cytoplasmic pool of iron is released from cultured cells via temperature-dependent mechanical wounding

Richardson, D. R., Dickson, L., & Baker, E. (1996) · In Vitro Cellular & Developmental Biology - Animal

Iron Metabolism and DisordersPlant Micronutrient Interactions and Effects

Cited by 4